SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Sun Nan)
 

Sökning: WFRF:(Sun Nan) > Gubenyiliu II Inhib...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004539naa a2200505 4500
001oai:DiVA.org:uu-330060
003SwePub
008171116s2017 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3300602 URI
024a https://doi.org/10.3390/molecules220507872 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Zhang, Yiu Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Oncol, Beijing 100010, Peoples R China.4 aut
2451 0a Gubenyiliu II Inhibits Breast Tumor Growth and Metastasis Associated with Decreased Heparanase Expression and Phosphorylation of ERK and AKT Pathways
264 c 2017-05-15
264 1b MDPI AG,c 2017
338 a electronic2 rdacarrier
520 a Gubenyiliu II (GYII), a Traditional Chinese Medicine (TCM) formula used in our hospital, has shown beneficial effects in cancer patients. In this study, we investigated the molecular mechanisms underlying the beneficial effects of GYII on murine breast cancer models. GYII showed significant inhibitory effects on tumor growth and metastasis in the murine breast cancer model. Additionally, GYII suppressed the proliferation of 4T1 and MCF-7 cells in a dose-dependent manner. A better inhibitory effect on 4T1 cell proliferation and migration was found in the decomposed recipes (DR) of GYII. Moreover, heparanase expression and the degree of angiogenesis were reduced in tumor tissues. Western blot analysis showed decreased expression of heparanase and growth factors in the cells treated with GYII and its decomposed recipes (DR2 and DR3), and thereby a reduction in the phosphorylation of extracellular signal-regulated kinase (ERK) and serine-threonine kinase (AKT). These results suggest that GYII exerts anti-tumor growth and anti-metastatic effects in the murine breast cancer model. The anti-tumor activity of GYII and its decomposed recipes is, at least partly, associated with decreased heparanase and growth factor expression, which subsequently suppressed the activation of the ERK and AKT pathways.
650 7a NATURVETENSKAPx Kemix Organisk kemi0 (SwePub)104052 hsv//swe
650 7a NATURAL SCIENCESx Chemical Sciencesx Organic Chemistry0 (SwePub)104052 hsv//eng
653 a Gubenyiliu II
653 a breast tumor
653 a heparanase
653 a growth factors
653 a ERK and AKT pathways
700a Zhang, Gan-Linu Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Oncol, Beijing 100010, Peoples R China.4 aut
700a Sun, Xuu Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Oncol, Beijing 100010, Peoples R China.4 aut
700a Cao, Ke-Xinu Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Oncol, Beijing 100010, Peoples R China.4 aut
700a Shang, Ya-Wenu Capital Med Univ, Sch Tradit Chinese Med, Beijing 100069, Peoples R China.4 aut
700a Gong, Mu-Xinu Capital Med Univ, Sch Tradit Chinese Med, Beijing 100069, Peoples R China.4 aut
700a Ma, Congu Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Oncol, Beijing 100010, Peoples R China.4 aut
700a Nan, Nanu Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Oncol, Beijing 100010, Peoples R China.4 aut
700a Li, Jin-Pingu Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi,Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Oncol, Beijing 100010, Peoples R China.4 aut0 (Swepub:uu)jinpili
700a Yu, Ming-Weiu Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Oncol, Beijing 100010, Peoples R China.4 aut
700a Yang, Guo-Wangu Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Oncol, Beijing 100010, Peoples R China.4 aut
700a Wang, Xiao-Minu Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Oncol, Beijing 100010, Peoples R China.4 aut
710a Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Oncol, Beijing 100010, Peoples R China.b Capital Med Univ, Sch Tradit Chinese Med, Beijing 100069, Peoples R China.4 org
773t Moleculesd : MDPI AGg 22:5q 22:5x 1431-5157x 1420-3049
856u https://uu.diva-portal.org/smash/get/diva2:1157733/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
856u https://www.mdpi.com/1420-3049/22/5/787/pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-330060
8564 8u https://doi.org/10.3390/molecules22050787

Hitta via bibliotek

  • Molecules (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy